显示所有

COVAX announces new agreement, plans for first deliveries

这 COVAX Facility has announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer/BioNTech COVID-19 vaccine.

COVAX is on track to deliver at least 2 billion doses of COVID-19 vaccines by the end of the 2021, including at least 1.3 billion doses to 92 lower income countries.

For more information please follow the link below:

Gavi: COVAX announces new agreement, plans for first deliveries

经过 雷切尔麦奎尔

ATAGI advice on influenza and COVID-19 vaccines

这 澳大利亚免疫技术咨询小组 (ATAGI) have published advice related to the administration of influenza and COVID-19 vaccines.

Due to a lack of safety and immunogenicity data on the co-administration of these vaccines, it is therefore recommended that influenza and COVID-19 vaccines are not administered on the same day, but with a minimum interval of 14 days. There is no preference regarding the order of vaccine administration, noting that both the Oxford/AstraZeneca and Pfizer/BioNTech COVID-19 vaccines require a 2-dose schedule. If influenza and COVID-19 vaccines are inadvertently administered on the same day or are administered within a shorter timeframe than 14 days, revaccination with either vaccine is not recommended.

To read the advice in full, refer to the link below:

ATAGI advice on influenza and COVID-19 vaccines

经过 艾丽丝·布莱克

Mobilising Australia’s COVID-19 vaccine workforce

The Australian Government have confirmed that COVID-19 vaccine delivery will be carried out by hospitals, general practices, state and commonwealth vaccination clinics, Aboriginal Community Controlled Health Organisations and Pharmacies.

To supplement our already established vaccine workforce, and assist in vaccine delivery to outreach locations, Aspen Medical, Healthcare Australia, International SOS, and Sonic Clinical Services have been contracted to support each jurisdiction in their vaccine program.

To read the announcement in full, follow the below link:

Mobilising Australia’s COVID-19 vaccine workforce

经过 雷切尔麦奎尔

GACVS COVID-19 Vaccine Safety subcommittee meeting to review reports of deaths of very frail elderly individuals vaccinated with Pfizer BioNTech COVID-19 vaccine, BNT162b2

The role of the Global Advisory Committee on Vaccine Safety (GACVS) is to provide independent, expert advice to the World Health Organization on the safety of vaccines.

On January 19 2021 a virtual meeting was held to review all available information on the deaths reported in frail, elderly individuals who had received the Pfizer/BioNTech COVID-19 vaccine. Following this review, it was concluded that vaccination has not contributed to any unexpected or increase in number of fatalities in this patient group. As such, there is no change in recommendations around safety of the Pfizer/BioNTech COVID-19 vaccine.

要了解更多信息，请点击以下链接：

WHO: GACVS COVID-19 Vaccine Safety subcommittee meeting to review reports of deaths of very frail elderly individuals vaccinated with Pfizer BioNTech COVID-19 vaccine, BNT162b2

经过 艾丽丝·布莱克

COVID-19 vaccine rollout: Primary care participation in Phase 1b–call for expressions of interest from General Practices

In preparation for the rollout of COVID-19 vaccines in Australia, accredited general practices are invited to express their interest in participating in Phase 1b of the COVID-19 Vaccination Program.

Phase 1b of the COVID-19 Vaccination Program is dedicated to delivering 14.8 million doses of the University of Oxford/AstraZeneca COVID-19 vaccine (dependant on TGA approval).

The Phase 1b priority populations include:
- People aged 70 years and over
- Aboriginal and Torres Strait Islander adults
- Critical and high-risk workers including defence, police, fire, emergency services and meat
processing
- Health care workers other than those prioritised in Phase 1a, including (but not limited to)
hospitals, general practices, pharmacists, allied health, and other healthcare services in the
community
- People at increased risk of severe disease

For further information, including how to register your interest, please follow the link below:

COVID-19 vaccine rollout: Primary care participation in Phase 1b–call for expressions of interest from General Practices

经过 雷切尔麦奎尔

CNN: How some states are administering Covid-19 vaccines at twice the speed of others

Data from the CDC reveals that of the 31 million doses of COVID-19 vaccine that have been distributed to the various jurisdictions in the United States, only 39% (12.2 million doses) have actually been administered. Those states with the highest vaccination rates have suggested that preparation, communication and strategic planning have been vital in vaccine rollout.

要阅读更多信息，请点击以下链接：

CNN: How some states are administering Covid-19 vaccines at twice the speed of others

经过 艾丽丝·布莱克

ABC 电台：尽管有老年人死亡，挪威仍将继续使用辉瑞的新冠疫苗

挪威药品管理局医疗主任 Steinar Madsen 博士接受了 ABC 电台采访，讨论了最近老年人接种辉瑞/BioNTech COVID-19 疫苗后死亡的报道。虽然调查正在进行中，但他强调副作用很少见，挪威将继续使用这种疫苗，作为其 COVID-19 疫苗推广的一部分。

要收听采访，请点击以下链接：

ABC 电台：尽管有老年人死亡，挪威仍将继续使用辉瑞的新冠疫苗

经过 艾丽丝·布莱克